Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pyxis Oncology (PYXS) Shares Outstanding (Weighted Average): 2024-2025

Historic Shares Outstanding (Weighted Average) for Pyxis Oncology (PYXS) over the last 2 years, with Sep 2025 value amounting to $62.0 million.

  • Pyxis Oncology's Shares Outstanding (Weighted Average) rose 5.22% to $62.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $62.0 million, marking a year-over-year increase of 5.22%. This contributed to the annual value of $59.5 million for FY2024, which is 2.29% up from last year.
  • Pyxis Oncology's Shares Outstanding (Weighted Average) amounted to $62.0 million in Q3 2025, which was up 0.11% from $61.9 million recorded in Q2 2025.
  • Pyxis Oncology's Shares Outstanding (Weighted Average)'s 5-year high stood at $62.0 million during Q3 2025, with a 5-year trough of $58.1 million in Q1 2024.
  • In the last 2 years, Pyxis Oncology's Shares Outstanding (Weighted Average) had a median value of $59.5 million in 2024 and averaged $60.1 million.
  • Data for Pyxis Oncology's Shares Outstanding (Weighted Average) shows a peak YoY grew of 5.95% (in 2025) over the last 5 years.
  • Over the past 2 years, Pyxis Oncology's Shares Outstanding (Weighted Average) (Quarterly) stood at $59.5 million in 2024, then climbed by 5.22% to $62.0 million in 2025.
  • Its last three reported values are $62.0 million in Q3 2025, $61.9 million for Q2 2025, and $61.6 million during Q1 2025.